Literature DB >> 24095254

The effect of the coumarin-like derivative osthole on the osteogenic properties of human periodontal ligament and jaw bone marrow mesenchymal stem cell sheets.

Li-Na Gao1, Ying An, Ming Lei, Bei Li, Hao Yang, Hong Lu, Fa-Ming Chen, Yan Jin.   

Abstract

Cell sheet engineering is a scaffold-free delivery concept that has been shown to improve mesenchymal stem cell-mediated regeneration of injured or pathologically damaged periodontal tissues in preclinical studies and several clinical trials. However, the best strategy for cell sheet production remains to be identified. The aim of this study was to investigate the biological effects of osthole, a coumarin-like derivative extracted from Chinese herbs, on the cell sheet formation and osteogenic properties of human periodontal ligament stem cells (PDLSCs) and jaw bone marrow mesenchymal stem cells (JBMMSCs). Patient-matched PDLSCs and JBMMSCs were isolated, and an appropriate concentration of osthole for cell culture was screened for both cell types in terms of cell proliferation and alkaline phosphatase (ALP) activity. Next, the best mode of osthole stimulation for inducing the formation of sheets by each cell type was selected by evaluating the amount of their extracellular matrix (ECM) protein production as well as osteogenic-related gene expression. Furthermore, both PDLSC and JBMMSC sheets obtained from each optimized technique were transplanted subcutaneously into nude mice to evaluate their capacity for ectopic bone regeneration. The results revealed that 10(-5) m/L osthole significantly enhanced the proliferation of both PDLSCs and JBMMSCs (P < 0.05), although for JBMMSCs, there was no concentration-related change among the four established osthole groups (P > 0.05). In addition, 10(-5) m/L osthole was the best concentration to promote the ALP activities of both cells (P < 0.01). Based on both the production of ECM proteins (collagen type I, integrin β1, and fibronectin) and the expression of osteogenic genes (ALP, Runt-related transcription factor 2 (RUNX2), and osteocalcin (OCN)), the provision of 10(-5) m/L osthole throughout the entire culture stage (10 days) for PDLSCs or at the early stage (first 3 days) for JBMMSCs was the most effective osthole administration mode for cell sheet formation (P < 0.05). The results of in vivo transplantation showed that osthole-mediated PDLSC and JBMMSC sheets formed more new bone than those obtained without osthole intervention (P < 0.001). Our data suggest that a suitable concentration and mode of osthole stimulation may enhance ECM production and positively affect cell behavior in cell sheet engineering.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell sheet engineering; Extracellular matrix protein production; Osteogenic differentiation; Osthole; Periodontal regeneration; Scaffold-free cell delivery

Mesh:

Substances:

Year:  2013        PMID: 24095254     DOI: 10.1016/j.biomaterials.2013.09.017

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  29 in total

1.  Advancing biomaterials of human origin for tissue engineering.

Authors:  Fa-Ming Chen; Xiaohua Liu
Journal:  Prog Polym Sci       Date:  2015-03-28       Impact factor: 29.190

2.  Osthole improves function of periodontitis periodontal ligament stem cells via epigenetic modification in cell sheets engineering.

Authors:  Jin Sun; Zhiwei Dong; Yang Zhang; Xiaoning He; Dongdong Fei; Fang Jin; Lin Yuan; Bei Li; Yan Jin
Journal:  Sci Rep       Date:  2017-07-12       Impact factor: 4.379

3.  Allogeneic Mesenchymal Stem Cell Therapy Promotes Osteoblastogenesis and Prevents Glucocorticoid-Induced Osteoporosis.

Authors:  Bingdong Sui; Chenghu Hu; Xinyi Zhang; Pan Zhao; Tao He; Cuihong Zhou; Xinyu Qiu; Nan Chen; Xinyi Zhao; Yan Jin
Journal:  Stem Cells Transl Med       Date:  2016-06-30       Impact factor: 6.940

4.  [Construction and preliminary study on biological characteristics of composite cell sheets of mesenchymal stem cells and endothelial progenitor cells derived from peripheral blood].

Authors:  Fei Xing; Xin Duan; Ming Liu; Jialei Chen; Cheng Long; Ran Chen; Jiachen Sun; Shuang Wu; Li Chen; Zhou Xiang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-01-15

Review 5.  Osteogenic Potential of Dental Mesenchymal Stem Cells in Preclinical Studies: A Systematic Review Using Modified ARRIVE and CONSORT Guidelines.

Authors:  Murali Ramamoorthi; Mohammed Bakkar; Jack Jordan; Simon D Tran
Journal:  Stem Cells Int       Date:  2015-05-28       Impact factor: 5.443

6.  The use of platelet-rich fibrin combined with periodontal ligament and jaw bone mesenchymal stem cell sheets for periodontal tissue engineering.

Authors:  Zhong-Shan Wang; Zhi-Hong Feng; Guo-Feng Wu; Shi-Zhu Bai; Yan Dong; Fa-Ming Chen; Yi-Min Zhao
Journal:  Sci Rep       Date:  2016-06-21       Impact factor: 4.379

7.  Influence of nanotopography on periodontal ligament stem cell functions and cell sheet based periodontal regeneration.

Authors:  Hui Gao; Bei Li; Lingzhou Zhao; Yan Jin
Journal:  Int J Nanomedicine       Date:  2015-06-19

8.  Human Umbilical Cord MSCs as New Cell Sources for Promoting Periodontal Regeneration in Inflammatory Periodontal Defect.

Authors:  Fengqing Shang; Shiyu Liu; Leiguo Ming; Rong Tian; Fang Jin; Yin Ding; Yongjie Zhang; Hongmei Zhang; Zhihong Deng; Yan Jin
Journal:  Theranostics       Date:  2017-09-26       Impact factor: 11.600

9.  Curcumin-mediated bone marrow mesenchymal stem cell sheets create a favorable immune microenvironment for adult full-thickness cutaneous wound healing.

Authors:  Zhi Yang; Chengmin He; Jinyang He; Jing Chu; Hanping Liu; Xiaoyuan Deng
Journal:  Stem Cell Res Ther       Date:  2018-01-31       Impact factor: 6.832

10.  The effects of conditioned media generated by polarized macrophages on the cellular behaviours of bone marrow mesenchymal stem cells.

Authors:  Xiao-Tao He; Xuan Li; Yuan Yin; Rui-Xin Wu; Xin-Yue Xu; Fa-Ming Chen
Journal:  J Cell Mol Med       Date:  2017-11-06       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.